PriceTargets.com logo

NASDAQ:AXON - Axon Enterprise Stock Price Target and Predictions

  • Consensus Rating: Buy
  • Consensus Price Target: $206.13
  • Forecasted Upside: 50.27 %
  • Number of Analysts: 9
  • Breakdown:
  • 0 Sell Ratings
  • 1 Hold Ratings
  • 7 Buy Ratings
  • 1 Strong Buy Ratings
$137.17 As of 01/14/2022 01:00 AM ET
▼ -6.48 (-4.51%)

This chart shows the closing price for AXON by one month, three months, or twelve months.

Skip Closing Price Chart
1 month | 3 months | 12 months
Get New Axon Enterprise Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for AXON and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for AXON

Analyst Price Target is $206.13
▲ +50.27% Upside Potential
This price target is based on 9 analysts offering 12 month price targets for Axon Enterprise in the last 3 months. The average price target is $206.13, with a high forecast of $250.00 and a low forecast of $170.00. The average price target represents a 50.27% upside from the last price of $137.17.

This chart shows the closing price for AXON for the last year in relation to the current analyst high, average, and low pricetarget.

Read Analyst Price Chart DescriptionSkip Analyst Price Chart

Current Consensus is Buy

The current consensus among 9 polled investment analysts is to buy stock in Axon Enterprise.

Past Monthly Recommendations

Move your mouse over past months for details

Read Past Recommendations DescriptionSkip Past Price Target Consensus Chart
  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
7/26/2020
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
10/24/2020
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
1/22/2021
  • 0 strong buy ratings
  • 4 buy ratings
  • 1 hold ratings
  • 0 sell ratings
Ratings as of
4/22/2021
  • 1 strong buy ratings
  • 4 buy ratings
  • 1 hold ratings
  • 0 sell ratings
Ratings as of
7/21/2021
  • 1 strong buy ratings
  • 4 buy ratings
  • 1 hold ratings
  • 0 sell ratings
Ratings as of
10/19/2021
  • 1 strong buy ratings
  • 7 buy ratings
  • 1 hold ratings
  • 0 sell ratings
Ratings as of
12/18/2021
  • 1 strong buy ratings
  • 7 buy ratings
  • 1 hold ratings
  • 0 sell ratings
Ratings as of
1/17/2022

Latest Recommendations

  • 1 strong buy ratings
  • 7 buy ratings
  • 1 hold ratings
  • 0 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
12/15/2021Morgan StanleyLower Price TargetOverweight$200.00 ➝ $180.00Low
12/14/2021JMP SecuritiesInitiated CoverageOutperform$195.00High
11/16/2021William BlairReiterated RatingOutperformHigh
11/16/2021Craig HallumUpgradeHold ➝ Buy$232.00High
8/6/2021Raymond JamesBoost Price TargetStrong-Buy$200.00 ➝ $223.00Medium
8/6/2021Needham & Company LLCBoost Price TargetBuy$190.00 ➝ $250.00Low
8/6/2021Robert W. BairdBoost Price TargetPositive ➝ Outperform$195.00 ➝ $220.00High
6/30/2021Raymond JamesBoost Price TargetStrong-Buy$150.00 ➝ $200.00Low
5/19/2021Raymond JamesUpgradeMarket Perform ➝ Strong-Buy$150.00High
2/26/2021Northland SecuritiesInitiated CoverageBuy$170.00Medium
2/26/2021Needham & Company LLCReiterated RatingBuyHigh
2/26/2021Robert W. BairdBoost Price TargetOutperform$135.00 ➝ $200.00High
2/12/2021JPMorgan Chase & Co.DowngradeOverweight ➝ Neutral$129.00 ➝ $179.00Low
2/1/2021Morgan StanleyInitiated CoverageOverweight$185.00Low
10/23/2019JMP SecuritiesReiterated RatingOutperform$28.00 ➝ $32.00Low
2/11/2019JMP SecuritiesReiterated RatingBuy$6.00Medium
12/17/2018Jefferies Financial GroupUpgradeHold ➝ Buy$3.00High
11/11/2018OppenheimerReiterated RatingHoldHigh
9/20/2018CowenReiterated RatingHoldLow
8/13/2018HC WainwrightReiterated RatingBuy$7.00Medium
7/9/2018OppenheimerReiterated RatingHoldLow
6/12/2018OppenheimerReiterated RatingHoldLow
6/11/2018Jefferies Financial GroupBoost Price TargetHold$3.00 ➝ $5.00High
6/7/2018HC WainwrightReiterated RatingBuyHigh
6/6/2018OppenheimerReiterated RatingHoldHigh
6/6/2018Chardan CapitalReiterated RatingHold$4.00High
2/13/2018CowenReiterated RatingHoldHigh
2/13/2018OppenheimerReiterated RatingHoldHigh
1/12/2018CowenDowngradeOutperform ➝ Market PerformHigh
1/10/2018Chardan CapitalUpgradeSell ➝ Neutral$2.50 ➝ $2.50Low
12/21/2017Jefferies Financial GroupDowngradeBuy ➝ Hold$6.00High
12/1/2017HC WainwrightReiterated RatingBuy$11.00Medium
11/12/2017OppenheimerReiterated RatingHoldN/A
11/10/2017Piper Jaffray CompaniesReiterated RatingHoldN/A
11/3/2017Chardan CapitalReiterated RatingSell$3.00N/A
11/1/2017Robert W. BairdReiterated RatingHold$6.00N/A
10/19/2017HC WainwrightReiterated RatingBuyN/A
10/6/2017Chardan CapitalReiterated RatingSell$3.00N/A
9/27/2017HC WainwrightReiterated RatingBuy$11.00Low
9/27/2017Jefferies Financial GroupReiterated RatingBuy$12.00High
9/26/2017Evercore ISIReiterated RatingOutperform$30.00 ➝ $9.00High
9/26/2017CowenReiterated RatingOutperform$30.00 ➝ $25.00High
9/26/2017OppenheimerDowngradeOutperform ➝ Market PerformHigh
9/26/2017JMP SecuritiesReiterated RatingOutperform$36.00 ➝ $19.00N/A
9/26/2017Piper Jaffray CompaniesDowngradeOverweight ➝ Neutral$32.00 ➝ $9.00N/A
9/26/2017UBS GroupDowngradeOutperform ➝ Market PerformN/A
9/26/2017Robert W. BairdDowngradeOutperform ➝ Neutral$29.00 ➝ $6.00N/A
9/25/2017OppenheimerReiterated RatingOutperform ➝ Buy$30.00High
9/23/2017Chardan CapitalReiterated RatingSell ➝ Sell$3.00High
9/14/2017Chardan CapitalReiterated RatingSell$8.00Medium
9/8/2017Evercore ISIInitiated CoverageOutperform ➝ Outperform$30.00High
8/25/2017Jefferies Financial GroupSet Price TargetBuy$40.00High
7/10/2017Jefferies Financial GroupInitiated CoverageBuy ➝ Buy$40.00Low
6/21/2017CowenReiterated RatingOutperform$30.00Medium
6/14/2017CIBCBoost Price TargetOutperform ➝ Outperform$26.00 ➝ $30.00High
6/14/2017OppenheimerBoost Price TargetOutperform$26.00 ➝ $30.00Medium
6/13/2017CowenReiterated RatingOutperform$22.00 ➝ $30.00High
6/9/2017Jefferies Financial GroupReiterated RatingBuy$31.00Low
4/18/2017CIBCBoost Price TargetNeutral$30.00 ➝ $33.00Low
4/18/2017Jefferies Financial GroupReiterated RatingBuy$31.00Low
4/17/2017OppenheimerBoost Price TargetNeutral$30.00 ➝ $33.00Low
4/14/2017OppenheimerReiterated RatingOutperform$20.00 ➝ $26.00Low
4/12/2017Piper Jaffray CompaniesReiterated RatingOverweight$32.00Low
3/22/2017OppenheimerReiterated RatingBuyMedium
2/14/2017HC WainwrightSet Price TargetBuy$35.00N/A
2/14/2017CowenInitiated CoverageOutperformN/A
2/13/2017Piper Jaffray CompaniesReiterated RatingPositive$32.00N/A
2/9/2017OppenheimerSet Price TargetBuy$20.00N/A
2/3/2017CowenInitiated CoverageOutperform$22.00N/A
(Data available from 1/17/2017 forward)

News Sentiment Rating

0.81 (Buy)

Our news sentiment rating is based on the average sentiment of articles about this company published in the media in the last 30 days of headlines and can range from 2 (very positive sentiment) to -2 (very negative sentiment).

News Sentiment Over Time

Move your mouse over past months for details

Skip to Current Sentiment Summary
  • 0 very positive mentions
  • 2 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
6/21/2021
  • 5 very positive mentions
  • 5 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
7/21/2021
  • 1 very positive mentions
  • 10 positive mentions
  • 2 negative mentions
  • 0 very negative mentions
Mentions as of
8/20/2021
  • 3 very positive mentions
  • 2 positive mentions
  • 1 negative mentions
  • 0 very negative mentions
Mentions as of
9/19/2021
  • 5 very positive mentions
  • 2 positive mentions
  • 1 negative mentions
  • 1 very negative mentions
Mentions as of
10/19/2021
  • 3 very positive mentions
  • 12 positive mentions
  • 1 negative mentions
  • 0 very negative mentions
Mentions as of
11/18/2021
  • 7 very positive mentions
  • 13 positive mentions
  • 1 negative mentions
  • 0 very negative mentions
Mentions as of
12/18/2021
  • 4 very positive mentions
  • 4 positive mentions
  • 1 negative mentions
  • 0 very negative mentions
Mentions as of
1/17/2022

Current Sentiment

  • 4 very positive mentions
  • 4 positive mentions
  • 1 negative mentions
  • 0 very negative mentions

Recent Stories by Sentiment

Very Negative

  • No very negative mentions tracked during this time.

Negative

Positive

Very Positive

Axon Enterprise logo
Axon Enterprise, Inc. engages in the development, manufacturing, and sale of conducted electrical weapons for personal defense. It operates through the TASER Weapons and Software and Sensors segments. The TASER Weapons segment sells conducted electrical weapons, accessories, and other related products and services. The Software and Sensors segment includes devices, wearables, applications, cloud, and mobile products. The company was founded by Patrick W. Smith and Thomas P. Smith on September 7, 1993 and is headquartered in Scottsdale, AZ.
Read More

Today's Range

Now: $137.17
Low: $135.15
High: $143.13

50 Day Range

MA: $158.43
Low: $137.17
High: $181.94

52 Week Range

Now: $137.17
Low: $121.09
High: $212.37

Volume

633,004 shs

Average Volume

684,190 shs

Market Capitalization

$9.39 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.37

Frequently Asked Questions

What sell-side analysts currently cover shares of Axon Enterprise?

The following equities research analysts have issued reports on Axon Enterprise in the last twelve months: Craig Hallum, JMP Securities, JPMorgan Chase & Co., Morgan Stanley, Needham & Company LLC, Northland Securities, Raymond James, Robert W. Baird, William Blair, and Zacks Investment Research.
View the latest analyst ratings for AXON.

What is the current price target for Axon Enterprise?

8 Wall Street analysts have set twelve-month price targets for Axon Enterprise in the last year. Their average twelve-month price target is $206.13, suggesting a possible upside of 50.3%. Needham & Company LLC has the highest price target set, predicting AXON will reach $250.00 in the next twelve months. Northland Securities has the lowest price target set, forecasting a price of $170.00 for Axon Enterprise in the next year.
View the latest price targets for AXON.

What is the current consensus analyst rating for Axon Enterprise?

Axon Enterprise currently has 1 hold rating, 7 buy ratings and 1 strong buy rating from Wall Street analysts. The stock has a consensus analyst rating of "Buy." A "buy" rating indicates that analysts believe AXON will outperform the market and that investors should add to their positions of Axon Enterprise.
View the latest ratings for AXON.

What other companies compete with Axon Enterprise?

Other companies that are similar to Axon Enterprise include Microsoft, Oracle, ServiceNow, VMware, Fortinet, Qualys, Commvault Systems, C3.ai, Progress Software and FalconStor Software.

How do I contact Axon Enterprise's investor relations team?

Axon Enterprise's physical mailing address is 20-22 BEDFORD ROW, LONDON X0, WC1R 4JS. The biotechnology company's listed phone number is (480) 991-0797 and its investor relations email address is [email protected] The official website for Axon Enterprise is www.axovant.com.